Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,368,390
+$993,837 QoQ
Shares Held
692,518
+1.9% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. DSGN ranks #184 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,368,390 | 692,518 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,374,553 | 679,590 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $5,237,965 | 695,613 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,675,806 | 794,008 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,993,417 | 775,497 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,699,317 | 761,640 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,080,998 | 758,550 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,371,702 | 707,971 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,756,108 | 683,898 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,756,271 | 662,744 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,497,939 | 634,720 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,012,123 | 636,845 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,652,456 | 633,008 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,186,913 | 603,013 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $9,642,574 | 576,709 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,091,750 | 435,125 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,922,931 | 366,745 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $7,524,351 | 351,441 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,790,490 | 258,032 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,027,396 | 252,760 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,127,230 | 37,700 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||